July 31, Top 20 Shareholders
July 31_Top_Holders_Report – 2021-08-03T081238.496
July 30, Virtual Investor Briefing for August 12, 2021
210730_Virtual Investor Briefing
July 28, Appendix 4C and Quarterly Update
210728_Appendix 4C and Q Update
July 26, PharmAust Update on COVID-19 Work
210726_PAA_Covid_update
July 12, PharmAust and WEHI Investigate Monepantel in HTLV-1 infection
210712_PharmAust and WEHI Investigate Monepantel in HTLV-1
July 9, PharmAust ANZCVS Science Week Presentation
210709_Science Week Slides
July 7, Update on Ongoing MPL GMP Tablet Tablet Stability
210707_GMP Stability Update
June 30, Top 20 Shareholders
June 30, Top 20 Shareholders
June 28, Phase IIb Dog Cancer Interim Primary Endpoints Attained
210628_CanineInterimClinicalEndpoints
May 31, Top 20 Shareholders
210601_Top_Holders_Report – 2021-06-01T161455.048